Journal article

Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy

Amy R Brooks-Kayal, Kevin G Bath, Anne T Berg, Aristea S Galanopoulou, Gregory L Holmes, Frances E Jensen, Andres M Kanner, Terence J O'Brien, Vicky H Whittemore, Melodie R Winawer, Manisha Patel, Helen E Scharfman

Epilepsia | WILEY | Published : 2013

Grants

Awarded by Office of the Director



Awarded by NATIONAL INSTITUTE OF MENTAL HEALTH


Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE


Awarded by OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH


Funding Acknowledgements

Funding sources: R01NS38595 and grants from CURE, AES, the Epilepsy Foundation (EF) and the Colorado Center for Drug Discovery (ARB-K); NARSAD and EF (KGB); R37NS31146 and a grant from the Pediatric Epilepsy Foundation (ATB); R21NS078333 and R01NS020253 and grants from Autism Speaks, CURE, Heffer and Siegel Families Foundations (ASG); R01NS061991 and CURE (MRW); RO1NS039587, CURE, and Office of the Director grant R21NS072099 (MP); R01NS37562, R21MH090606, the Alzheimer's Association, and NYS Office of Mental Health (HES).